Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US7888325B2 · kind B2 · utility
6Cited by
64References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2006 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Nov 29, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Introduction of double stranded RNA into cells, cell culture, organs and tissues, and whole organisms, particularly vertebrates, specifically attenuates gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.